AI Verdict
CI has stronger fundamentals based on our AI analysis.
ABBV vs CI Fundamental Comparison
| Metric | ABBV | CI |
|---|---|---|
| Revenue | $61.2B | $274.9B |
| Net Income | $4.2B | $6.0B |
| Net Margin | 6.9% | 2.2% |
| ROE | N/A | 14.3% |
| ROA | 3.2% | 3.8% |
| Current Ratio | 0.67x | 0.85x |
| Debt/Equity | N/A | 0.74x |
| EPS | $2.36 | $22.18 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs CI: Frequently Asked Questions
Is ABBV or CI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CI has stronger fundamentals. ABBV is rated HOLD (70% confidence) while CI is rated BUY (76% confidence). This is not investment advice.
How does ABBV compare to CI fundamentally?
AbbVie Inc. has ROE of N/A vs Cigna Group's 14.3%. Net margins are 6.9% vs 2.2% respectively.
Which stock pays higher dividends, ABBV or CI?
ABBV has a dividend yield of N/A or no dividend while CI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or CI for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while CI has BUY rating with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs CI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs CI, the AI consensus favors CI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.